Navigation Links
InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
Date:1/9/2009

BRISBANE, Calif., Jan. 9 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it will conduct a conference call and webcast on Monday, January 12 at 8:30 a.m. EST to discuss results from its Phase 1b, 14-day study of hepatitis C virus (HCV) protease inhibitor ITMN-191 (R7227) in combination with Pegasys(R) (interferon alfa-2a) and Copegus(R) (ribavirin) in patients chronically infected with HCV genotype 1. ITMN-191 is being developed in collaboration with Roche.

To access the live teleconference, dial 888-799-0528 (U.S.) or 973-200-3372 (international), conference ID# 80676348. To access the live audio webcast of the conference call, please log on to the investor relations page of the company's website at http://www.intermune.com. The company recommends logging on to the site 15 minutes prior to the start of the presentation in order to register or download any necessary software.

A replay of the webcast and teleconference will be available approximately three hours after the call. The teleconference replay will be available for 10 business days following the call and can be accessed by dialing 800-642-1687 (U.S.) or 706-645-9291 (international), and entering the conference ID# 80676348.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology. InterMune has a research and development portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections. The pulmonology portfolio includes the Phase 3 program, CAPACITY, which is evaluating pirfenidone for the treatment of patients with IPF and a research program focused on small molecules for pulmonary disease. The hepatology
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
2. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
3. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
4. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
7. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
8. InterMune Announces Start of Phase 1b Trial of ITMN-191
9. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
10. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
11. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... BELOEIL, QC , Sept. 2, 2015 Demers ... Professionals (EEP) Inc. as their new dealer for the states ... and Tennessee . ... our customers," said Benoit Lafortune , Executive Vice-President for ... in Mississippi and Alabama ...
(Date:9/2/2015)... , Sept. 2, 2015  MiMedx Group, Inc. (NASDAQ: ... utilizing human amniotic tissue and patent-protected processes to ... the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, ... the inaccurate statements published by the Musculoskeletal Transplant ... 1, 2015. MTF,s September 1st press ...
(Date:9/2/2015)... 2, 2015 Unilife Corporation ("Unilife" or the ... developer, manufacturer and supplier of injectable drug delivery systems, ... of interest, the Company,s Board of Directors has engaged ... of strategic alternatives to maximize shareholder value. ... during the review process may include a possible sale ...
Breaking Medicine Technology:Demers Ambulances has named Emergency Equipment Professionals (EEP) Inc. as their dealer for the states of MS, AL and TN 2MiMedx Corrects A Second Inaccurate MTF Press Release 2MiMedx Corrects A Second Inaccurate MTF Press Release 3Unilife Announces Review of Strategic Alternatives 2
... Inc. (NYSE: LDR), will release financial results for the ... December 6, 2011. The company will host ... at 2:00 p.m. Eastern Time. Investors may access the live ... or 480-629-9692 (international callers), or by visiting the "Investors" page ...
... Nov. 22, 2011  Colorado Drug Card, in partnership with ... has agreed to be the "Preferred Pharmacy" for the ... to process prescriptions through Colorado Drug Card. Coloradans can ... pharmacist to process their prescription through the Colorado Drug ...
Cached Medicine Technology:Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2011 Results 2
(Date:9/2/2015)... ... September 02, 2015 , ... On ... Officers Association of America (MOAA) and Wounded Warrior Project® (WWP), will be ... Own,” expert panelists will lead interactive discussions on the responsibilities and commitments ...
(Date:9/2/2015)... ... , ... Telehealth represents a growing trend among Blue Cross and Blue Shield ... more than 12 Blues plan clients. The September 2015 issue of The ... trend, interviewing executives at Capital Blue Cross, whose telehealth services will launch next year. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... In “Failure ... by the Huffington Post on August 25th, writer Akela Stanfield detailed her lifelong struggle ... the author acknowledged that she had always seen herself as someone who would lose ...
(Date:9/2/2015)... ... 02, 2015 , ... Splashtop Inc., the worldwide leader in ... mirroring and extending product line -- Splashtop Wired XDisplay . Complementing ... setting, the new Splashtop Wired XDisplay delivers enhanced performance and reliability for users ...
(Date:9/2/2015)... ... ... Good health and a good cause paired up at The Barclays this past ... to the New Jersey Golf Foundation through its Healthy Steps Challenge. After making ... BCBSNJ challenged PGA TOUR golfer and NJ native Morgan Hoffmann to add more by ...
Breaking Medicine News(10 mins):Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 2Health News:MOAA and WWP host 2015 Warrior-Family Symposium Chairman of the Senate Committee on Veterans' Affairs and the Secretary of Veterans Affairs to Speak 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:Recent Editorial on Bariatric Surgery Acceptance Illuminates a Typical Journey Towards Weight Loss Surgery, Notes Dr. Michael Feiz 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 2Health News:Horizon BCBSNJ’s Healthy Steps Challenge Raises an Additional $6,000 for the NJ Golf Foundation with Help from PGA TOUR Golfer Morgan Hoffmann 3
... to warn Indonesians about bird flu will commence next week,. ... of 49 people in the country which ranks as ... to John Budd, head of communications with the United Nations ... several members of socio- religious groups will be involved in ...
... and vitamin D supplements is apparently of no use in ... //from the Women's Health Initiative study. Previous research had suggested ... risk. ,'We can't yet make a general recommendation ... each day as supplements,' said Dr. Rowan Chlebowski, the study's ...
... 200 elderly people in the Argyll and Bute Council area ... it has emerged//. Labour MSP Jackie Baillie said that the ... investigate. ,Argyll and Bute Council said it had ... that there were about 200 eligible people not receiving care, ...
... major Ranbaxy Laboratories Ltd today said its wholly owned ... //with Hyderabad-based Zenotech Laboratories Ltd to market generic cancer ... the agreement, Zenotech Labs would develop, submit for regulatory ... Ranbaxy would market these products as generic formulations in ...
... Togadiya, who underwent an angioplasty at a private hospital here, ... ,Togadiya was admitted to SAL hospital here yesterday, ... Bhupesh Shah carried out the angioplasty on Togadiya last night., ... of the leader is stable and he is expected to ...
... beer while watching the World Cup on television may be ... the game, says a new study. // ,Psychology ... are not confident of their sporting abilities are likely to ... ,The study, based on interviews with 31 London youths in ...
Cached Medicine News:
... The Featured Products ... at Mediflex and are ... modular in regular or ... come equipped with insulation, ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: